Yesterday, Frank Bienvenido Perez Diaz, a Venezuelan national, was sentenced to five years in a U.S. prison for his engagement in fentanyl trafficking. The 42-year-old had earlier in July pleaded guilty to distribution and possession with intent to distribute more than 40 grams of the substance as confirmed by the United States Attorney's Office, District of Massachusetts.
This particular case is a component of the Organized Crime Drug Enforcement Task Forces (OCDETF) program. The program employs a prosecutor-led, intelligence-driven, multi-agency drive to identify, disrupt, and dismantle top-ranked criminal drug organizations. Amid the growing intensity of the opioid crisis and increasing overdose deaths, cases like these highlight the nation's ongoing struggle against the circulation of lethal substances.
Over a period of a year, Perez Diaz had multiple discussions about the sale of controlled substances with a cooperative witness, involving kilos of fentanyl. On April 16, 2021, Perez Diaz traded over 2,000 counterfeit fentanyl pills to the cooperative witness. Fentanyl is a potent synthetic opioid, far more potent than opioids like morphine and heroin, heightening the risk for users. The wide-scale distribution of these counterfeit pills has resulted in widespread deaths and stretched law enforcement and public health resources.
